COMMUNIQUÉS West-GlobeNewswire

miRagen Therapeutics Announces New Data Showing Administration of MRG-110 Improved Tissue Perfusion and Wound Healing in Late Stage Preclinical Studies
27/04/2018
MRG-110 appeared to increase vascularization and reparative tissue formation in treated wounds; miRagen believes results support evaluation in human clinical trials MRG-110 treatment appeared to lead to more wounds [...]
Agios Announces Revised Starting Time of 8:00am ET for Investor Day and First Quarter 2018 Financial Results Webcast on Friday, May 4, 2018
27/04/2018
CAMBRIDGE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
Advantagene Announces Clinical Trial Collaboration
27/04/2018
Clinical Study to Combine GMCI™ with Opdivo® (nivolumab) in the Treatment of Malignant Glioma AUBURNDALE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Advantagene, Inc. today announced that the company entered into a [...]
AnaptysBio To Participate in Upcoming Investor Conferences
27/04/2018
SAN DIEGO, April 27, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]
Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering
27/04/2018
NEWTOWN, Pa., April 27, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]
Aino Health AB (publ): Aino Health AB signs cooperation agreement with Finla Occupational Health
27/04/2018
Aino Health and Finla Occupational Health have signed a cooperation agreement regarding Aino's HealthManager platform. Cooperation with Finla will further expand Aino's partner network and enable scalability and growth [...]
FIT Biotech Oy: APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH
27/04/2018
FIT Biotech Oy Company release 27.4.2018 at 11:00 AM EET APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH Tommi Holopainen, MSc Economics, EMBA, has been appointed as a new [...]
Decision on launch of conditional, voluntary offer
27/04/2018
Company announcement 27 April 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
GENFIT: First quarter 2018 financial information
27/04/2018
GENFIT: First quarter 2018 financial information (Unaudited financial information under IFRS) Cash and cash equivalents of €255.2 million at March 31, 2018 Revenues for the first three months of 2018 of €37 thousand [...]
GENFIT : Information financière du premier trimestre 2018
27/04/2018
GENFIT : Information financière du premier trimestre 2018 (Données non auditées établies selon les normes IFRS) Trésorerie et équivalents de trésorerie s'élevant à 255,2 millions d'euros au 31 mars 2018 Chiffre d' [...]
Xbrane Biopharma publishes 2017 Annual Report
27/04/2018
Press release 2018-04-27 Xbrane Biopharma AB's annual report for 2017 is now available at the company's website, www.xbrane.com . The annual report is distributed to the shareholders and others that made such request. [...]
Shire plc : Rule 2.9 Announcement
27/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 April 2018 [...]
Saniona publishes the Annual Report for 2017
27/04/2018
PRESS RELEASE April 27, 2018 Saniona, a leading biotech company in the field of ion channels, today announces that the English version of the Annual report for 2017 is now available on the company’s website www.saniona. [...]
Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018
27/04/2018
Company announcement - No. 13/2018 Zealand announces net sales of Soliqua ® 100/33 and Lyxumia ® /Adlyxin ® for the first quarter of 2018 Net sales of Soliqua ® 100/33 and Lyxumia ® /Adlyxin ® of EUR 14.5 million/USD 17 [...]
Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER
27/04/2018
Paris, April 27, 2018 First-quarter 2018 Business EPS (1) up 1.4% at CER Q1 2018 Change Change at CER IFRS net sales reported €7,898m -8.7% -0.4% IFRS net income reported €1,016m -82.2% (2) - IFRS EPS reported €0.81 -82 [...]
Sanofi : Hausse de 1,4% du BNPA des activités(1) à taux de change constants au premier trimestre 2018
27/04/2018
Paris, le 27 avril 2018 Hausse de 1,4% du BNPA des activités (1) à taux de change constants au premier trimestre 2018 T1 2018 Variation Variation à TCC Chiffre d'affaires net IFRS publié €7 898m -8,7% -0,4% Résultat net [...]
DBV Technologies Reports March 31, 2018 Cash Position
27/04/2018
Montrouge, France, April 27, 2018 DBV Technologies Reports March 31, 2018 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and cash equivalents as [...]
DBV Technologies publie sa position de trésorerie au 31 mars 2018
27/04/2018
Montrouge, France, le 27 avril (7H30 CEST), 2018 DBV Technologies publie sa position de trésorerie au 31 mars 2018 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]
Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018
27/04/2018
Mechelen, Belgium; 27 April 2018, 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) presents preclinical results showing broad beneficial effects on cartilage and bone with GLPG1972 in an osteoarthritis (OA) rat [...]

Pages